Skip NavigationSkip to Content
Return Return to Search Results

Transduction of rhesus macaque hematopoietic stem and progenitor cells with avian sarcoma and leukosis viral vectors

  1. Author:
    Hu, J. Q.
    Ferris, A.
    Larochelle, A.
    Krouse, A. E.
    Metzger, M. E.
    Donahue, R. E.
    Hughes, S. H.
    Dunbar, C. E.

  2. Author Address

    NHLBI, Mol Hematopoiesis Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA. NCI, HIV Drug Resistance Program, NIH, Ft Detrick, MD 21702 USA.;Dunbar, CE, NHLBI, Mol Hematopoiesis Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA.;dunbarc@nhlbi.nih.gov
    1. Year: 2007
    2. Date: Aug
  2. Journal: Human Gene Therapy
    1. 18
    2. 8
    3. Pages: 691-700
  4. Type of Article: Article
  5. ISSN: 1043-0342
  1. Abstract:

    Genome-wide integration site analyses showed that Moloney murine leukemia virus ( MoMLV)-and lentivirus-derived vectors integrate preferentially into the coding regions of genes, posing a risk of insertional mutagenesis. Avian sarcoma and leukosis viruses ( ASLVs) were previously reported to have a weak preference for gene-coding regions in a cell line study as compared with human immunodeficiency virus and MoMLV; however, thus far these vectors have not been studied for their potential efficacy in transduction of hematopoietic progenitor and stem cells. In this study we investigated for the first time the ability of ASLV-derived RCAS ( replication-competent ALV LTR [ avian leukosis virus long terminal repeat] with a splice acceptor) vectors to transduce rhesus macaque hematopoietic progenitors and long-term repopulating cells, in an autologous transplantation model. RCAS vectors can efficiently and stably transduce rhesus macaque CD34(+) hematopoietic progenitor cells with an efficiency of transduction of up to 34% ex vivo. In two animals transplanted with RCAS vector-transduced autologous CD34(+) cells, highly polyclonal hematopoietic reconstitution with sustained gene-marking levels in myeloid and lymphoid lineages was observed up to 18 months post-transplantation. These findings are encouraging and suggest that this vector system should be explored and further optimized for gene therapy applications targeting hematopoietic stem and progenitor cells.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1089/hum.2006.175
  3. View record in Web of Science®
  4. WOS: 000249124900002

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel